{"SPADE_UN_20323": {"Sequence Information": {"Peptide Name": "Ranatuerin-2PLx [K24S], R2PLx [K24S]", "Sequence": "GIMDTVKNAAKNLAGQLLDKLKCSITAC", "Sequence Length": 28, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells", "Pubmed ID": "30279210", "Reference": "Biosci Rep. 2018;38:", "Author": "Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30279210"}], "Mass": 2920.47, "PI": 8.82, "Net Charge": 2, "Hydrophobicity": 0.23, "Frequent Amino Acids": "AKL", "Absent Amino Acids": "EFHOPRUWY", "Basic Residues": 4, "Acidic Residues": 2, "Hydrophobic Residues": 14, "Polar Residues": 14, "Positive Residues": 4, "Negative Residues": 2, "SPADE ID": "SPADE_UN_20323", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11966", "Similarity": 1.0, "Sequence": "GIMDTVKNAAKNLAGQLLDKLK"}, {"SPADE_ID": "SPADE_UN_20323", "Similarity": 1.0, "Sequence": "GIMDTVKNAAKNLAGQLLDKLKCSITAC"}, {"SPADE_ID": "SPADE_N_05873", "Similarity": 0.9642857142857143, "Sequence": "GIMDTVKNAAKNLAGQLLDKLKCKITAC"}], "Hemolytic Activity": "Human microvascular endothelial cells HMEC-1:IC50=1185.00 µM,Horse erythrocytes:7% Hemolysis=512 µM,Horse erythrocytes:<5% Hemolysis=256 µM", "Target Organism": "Staphylococcus aureus NCTC 10788(MIC=>512µM),Staphylococcus aureus NCTC 10788(MBC=>512µM),Staphylococcus aureus ATCC 12493(MIC=>512µM),Staphylococcus aureus ATCC 12493(MBC=>512µM),Escherichia coli NCTC 10418(MIC=512µM),Escherichia coli NCTC 10418(MBC=>512µM),Enterococcus faecalis NCTC 12697(MIC=>512µM),Enterococcus faecalis NCTC 12697(MBC=>512µM),Pseudomonas aeruginosa ATCC 27853(MIC=>512µM),Pseudomonas aeruginosa ATCC 27853(MBC=>512µM),Candida albicans NCTC 1467(MIC=>512µM),Candida albicans NCTC 1467(MBC=>512µM),Human prostate adenocarcinoma PC-3(IC50=792.60µM),Human squamous lung carcinoma NCI-H157(IC50=58.18µM),Human breast adenocarcinoma MDA-MB-435(IC50=179.00µM),Human glioblastoma U251-MG(IC50=278.30µM),Human breast adenocarcinoma MCF-7(IC50=316.90µM)"}}}